Correlation Between Brompton Lifeco and Big Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brompton Lifeco and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brompton Lifeco and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brompton Lifeco Split and Big Pharma Split, you can compare the effects of market volatilities on Brompton Lifeco and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brompton Lifeco with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brompton Lifeco and Big Pharma.

Diversification Opportunities for Brompton Lifeco and Big Pharma

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Brompton and Big is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Brompton Lifeco Split and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and Brompton Lifeco is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brompton Lifeco Split are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of Brompton Lifeco i.e., Brompton Lifeco and Big Pharma go up and down completely randomly.

Pair Corralation between Brompton Lifeco and Big Pharma

Assuming the 90 days trading horizon Brompton Lifeco Split is expected to under-perform the Big Pharma. In addition to that, Brompton Lifeco is 2.04 times more volatile than Big Pharma Split. It trades about -0.07 of its total potential returns per unit of risk. Big Pharma Split is currently generating about -0.03 per unit of volatility. If you would invest  1,325  in Big Pharma Split on October 24, 2024 and sell it today you would lose (10.00) from holding Big Pharma Split or give up 0.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Brompton Lifeco Split  vs.  Big Pharma Split

 Performance 
       Timeline  
Brompton Lifeco Split 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Brompton Lifeco Split are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Brompton Lifeco may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Big Pharma Split 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Big Pharma Split has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy primary indicators, Big Pharma is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Brompton Lifeco and Big Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brompton Lifeco and Big Pharma

The main advantage of trading using opposite Brompton Lifeco and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brompton Lifeco position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.
The idea behind Brompton Lifeco Split and Big Pharma Split pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets